Stage II Breast Cancer Active Not Recruiting Phase 3 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02003209Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerTreatment